Caplin Point Laboratories arm gets USFDA nod for Neostigmine Methylsulfate Injection

New Delhi: Caplin Point Laboratories on Thursday said its subsidiary has received approval from the US health regulator for Neostigmine Methylsulfate Injection. Neostigmine Methylsulfate Injection is a cholinesterase inhibitor and is indicated for the reversal of the effects of non-depolariSing neuromuscular blocking agents (NMBAs) after surgery.

Caplin Steriles Ltd (Caplin) has been granted final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Neostigmine Methylsulfate Injection USP in the strengths of 5 mg/10 mL (0.5 mg/mL) and 10 mg/10 mL (1 mg/mL),” Caplin Point Laboratories said in a regulatory filing

Quoting IQVIA (IMS Health) data, Caplin Point Laboratories said Neostigmine Methylsulfate Injection had US sales data of approximately USD 20 million for the 12-month period ending Dec 2020.

  • Related Posts

    Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

    Rajkot: The Narcotics Control Bureau (NCB) on Monday said it has secured a “major conviction” in the case of illegal diversion of medical drugs involving a Haryana-based company via Gujarat’s Pipavav…

    Ayurveda practitioner fined by ISM Council for violation of professional ethics

    Thiruvanantpuram: The Ethics Committee of the Council of Indian Systems of Medicine, Kerala State Medical Councils, has imposed a fine of ₹50,000 on a registered Ayurveda practitioner for advertising his…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

    Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

    Ayurveda practitioner fined by ISM Council for violation of professional ethics

    Ayurveda practitioner fined by ISM Council for violation of professional ethics

    Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

    Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

    Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

    Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

    DoP may exempt 11 more drugs from public procurement rules

    DoP may exempt 11 more drugs from public procurement rules

    DoP calls for proposals to set up common facilities for medical device clusters

    DoP calls for proposals to set up common facilities for medical device clusters